Areej El-Jawahri, MD

Areej El-Jawahri, MD

Research Interests: Investigating patient-reported outcomes, developing interventions to enhance patient-centered decision-making, and designing supportive and palliative care interventions to improve the care of patients with hematologic malignancies and their families.

Overview

Biography

Areej El-Jawahri MD is an Instructor of Medicine at Harvard Medical School, Director of the Bone Marrow Transplant Survivorship Program at the Massachusetts General Hospital, and Associate Director of Massachusetts General Hospital Cancer Center Survivorship Program. Dr. El-Jawahri’s research focuses on improving the quality of life and care for patients with hematologic malignancies and their families, and addressing their palliative and supportive care and survivorship needs.

Research Interests

Dr. El-Jawahri is an oncologist specializing in the care of patients with hematologic malignancies and those undergoing hematopoietic stem cell transplantation. Her research goal is to improve the quality of life and care for patients with hematologic malignancies and their families. Dr. El-Jawahri’s research interests include investigating patient-reported outcomes, developing interventions to enhance patient-centered decision-making, and designing supportive and palliative care interventions to improve the care of patients with hematologic malignancies and their families.

She is also interested in exploring models of health care delivery to improve patients’ quality of life and end of life care and to enhance their prognostic understanding. Over the past several years, Dr. El-Jawahri has conducted numerous studies to explore patients’ and families’ prognostic understanding and develop video decision aids to promote patient-centered decision-making.

She has also studied extensively the supportive care needs of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation and is currently conducting a randomized clinical trial of a palliative care intervention for this population. Additionally, Dr. El-Jawahri has several ongoing studies developing and testing the efficacy of various interventions to improve the quality of life and care of hematopoietic stem cell transplant survivors and their families. These interventions target specific issues experienced by survivors such as sexual dysfunction and psychological distress.

Dr. El-Jawahri’s future goals are to continue to develop innovative interventions to improve the quality of life, prognostic understanding, patient-centered decision-making, and overall care of patients with hematologic malignancies throughout their illness trajectory.

Publications

Selected Publications

  1. El-Jawahri A, Vandusen HB, Traeger LN, Fishbein JN, Keenan T, Gallagher ER, Greer JA, Pirl WF, Jackson VA, Spitzer TR, Chen YA, Temel JS. Quality of life and mood predicts posttraumatic stress disorder after hematopoietic stem cell transplantation. Cancer 2015 Dec 9; PMID: 26650840.
  2. LeBlanc TW, El-Jawahri A. When and why should patients with hematologic malignancies see a palliative care specialist? Hematology Am Soc Hematol Educ Program 2015. Dec 5; PMID:26637760.
  3. El-Jawahri A, Li S, Ballen KK, Cutler C, Dey BR, Driscoll J, Hunnewell C, Ho VT, McAfee SL, Poliquin C, Saylor M, Soiffer RJ, Spitzer TR, Alyea E, Chen YB. Phase II trial of reduced-intensity busulfan/clofarabine conditioning with allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoid leukemia. Biol Blood Marrow Transplant 2015. Aug 7; PMID: 26260679.
  4. El-Jawahri A, Traeger L, Kuzmuk K, Eusebio J, Vandusen H, Shin J, Gallagher ER, Greer JA, Pirl WF, Jackson VA, Ballen KK, Spitzer TR, Graubert TA, McAfee S, Dey B, Chen YA, Temel JS. Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation. Bone Marrow Transplant. 2015 May 11; PMID: 25961772.
  5. El-Jawahri A, Abel GA, Steensma DP, LeBlanc TW, Fathi AT, Graubert T, DeAngelo DJ, Wadleigh M, Ballen KK, Foster JE, Attar EC, Amrein PC, Brunner AM, Stone RM, Temel JS. Health Care Utilization and End of Life Care for Older Patients with Acute Myeloid Leukemia. Cancer. 2015 Apr 29; PMID: 25926135.
  6. El-Jawahri A, Mitchell SL, Paasche-Orlow MK, Temel JS, Jackson VA, Rutledge RR, Parikh M, Davis A, Gillick MR, Barry MJ, Walker-Corkery ES, Chang Y, Cheng XS, Bazari H, Finn K, Coley C, Volandes AE. A randomized controlled trial of a CPR video decision support tool for hospitalized patients. Journal of General Internal Medicine 2015; Feb 18th. PMID 25691237.
  7. El-Jawahri A, Traeger L, Kuzmuk K, Eusebio J, Vandusen H, Shin J, Gallagher ER, Greer JA, Pirl WF, Jackson VA, Ballen KK, Spitzer TR, Graubert TA, McAfee S, Dey B, Chen YA, Temel JS. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation. Cancer. 2015 Mar 15;121(6):951-9. PMID: 25469752.
  8. El-Jawahri A, Pidala J, Inamoto Y, Chai X, Khera N, Wood WA, Cutler C, Arora M, Carpenter PA, Palmer J, Flowers M, Weisdorf D, Pavletic S, Jaglowski S, Jagasia M, Lee SJ, Chen YB. The impact of age on quality of life, functional status and survival in patients with chronic graft versus host disease. BBMT 2014 20 (9): 1341-8. PMID 24813171.
  9. El-Jawahri A, Chen YB. Pleiotropic approach to graft-versus-host disease. J Clin Oncol 2013. Dec 10; PMID 24166516.
  10. El-Jawahri A, Traeger L, Park ER, Greer JA, Pirl WF, Lennes IT, Jackson VA, Gallagher ER, Temel JS. Association among prognostic understanding, quality of life, and mood in patients with advanced cancer. Cancer 2014, 120 (2): 278-85. PMID 24122784.
  11. El-Jawahri A, Greer JA, Temel JS. Does palliative care improve outcomes for patients with incurable illness? A review of the evidence. J Support Oncol 2011. May-Jun 9; PMID 21702398.
  12. El-Jawahri A, Podgurski LM, Eichler AF, Plotkin SR, Temel SJ, Mitchell SL, Chang Y, Barry MJ, Volandes AE. Use of video to facilitate end-of-life discussions with cancer patients: a randomized controlled trial. Journal of Clinical Oncology 2010 28 (2): 305-10. PMID 19949010.

Back to Top